Gujarat Themis Biosyn Ltd
BSE:506879
Gujarat Themis Biosyn Ltd
Operating Income
Gujarat Themis Biosyn Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Gujarat Themis Biosyn Ltd
BSE:506879
|
Operating Income
₹696.2m
|
CAGR 3-Years
17%
|
CAGR 5-Years
63%
|
CAGR 10-Years
32%
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Operating Income
₹62.8B
|
CAGR 3-Years
25%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Operating Income
₹50.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
26%
|
CAGR 10-Years
11%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Operating Income
₹101.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
5%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Operating Income
₹39.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
15%
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Operating Income
₹15.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gujarat Themis Biosyn Ltd's Operating Income?
Operating Income
696.2m
INR
Based on the financial report for Dec 31, 2023, Gujarat Themis Biosyn Ltd's Operating Income amounts to 696.2m INR.
What is Gujarat Themis Biosyn Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
32%
Over the last year, the Operating Income growth was -1%. The average annual Operating Income growth rates for Gujarat Themis Biosyn Ltd have been 17% over the past three years , 63% over the past five years , and 32% over the past ten years .